Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YS | AZN | AMGN | GILD | BMY |
| Company | Ys Biopharma Co. Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9000 | 189.15 | 346.00 | 131.54 | 58.86 |
| High | 1.1000 | 189.94 | 347.66 | 132.32 | 59.21 |
| Low | 0.9000 | 187.56 | 342.52 | 129.28 | 58.35 |
| Latest | 1.0200 | 189.75 | 344.55 | 130.40 | 58.71 |
| Change | +0.1129 | -2.55 | -4.07 | -3.24 | -0.31 |
| % Change | +12.45% | -1.33% | -1.17% | -2.42% | -0.53% |
| Volume | 107,200 | 2,388,200 | 2,201,400 | 5,966,000 | 6,822,800 |
| 20-Day Average Volume | 81,165 | 1,930,735 | 2,456,120 | 5,270,985 | 9,516,970 |
| Previous Close | 0.9071 | 192.30 | 348.62 | 133.64 | 59.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8888 | 199.35 | 348.88 | 137.65 | 59.14 |
| 20-Day Raw Stochastic | 79.80% | 11.09% | 38.92% | 8.16% | 29.77% |
| 20-Day Relative Strength | 60.44 | 42.91 | 44.28 | 35.95 | 49.10 |
| Weighted Alpha | -21.89 | +32.35 | +21.12 | +21.37 | +26.06 |
| Today's Opinion | 88% Buy | 48% Buy | 8% Buy | 8% Buy | 48% Buy |
| Previous Opinion | 88% Buy | 64% Buy | 24% Buy | 24% Buy | 48% Buy |
| Last Month's Opinion | 48% Buy | 56% Buy | 56% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.31% since 05/17/24 | -7.35% since 04/17/26 | -3.03% since 04/17/26 | -5.26% since 04/17/26 | -2.43% since 04/17/26 |
| Low | 0.8810 on 05/22/24 | 187.56 on 04/24/26 | 340.06 on 04/21/26 | 129.28 on 04/24/26 | 57.79 on 04/21/26 |
| High | 1.1000 on 05/24/24 | 203.37 on 04/20/26 | 356.90 on 04/20/26 | 138.54 on 04/20/26 | 60.12 on 04/20/26 |
| 1-Month | |||||
| %Chg | +25.93% since 04/24/24 | +2.14% since 03/24/26 | -1.11% since 03/24/26 | -5.58% since 03/24/26 | +2.30% since 03/24/26 |
| Low | 0.7040 on 04/30/24 | 182.79 on 03/26/26 | 335.06 on 04/07/26 | 129.28 on 04/24/26 | 57.22 on 04/15/26 |
| High | 1.1000 on 05/24/24 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +158.29% since 02/23/24 | +2.07% since 01/23/26 | -0.06% since 01/23/26 | -4.07% since 01/23/26 | +7.43% since 01/23/26 |
| Low | 0.3800 on 03/01/24 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 129.28 on 04/24/26 | 54.21 on 01/29/26 |
| High | 1.1000 on 05/24/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +63.51% since 11/24/23 | +13.91% since 10/24/25 | +18.09% since 10/24/25 | +7.82% since 10/24/25 | +33.95% since 10/24/25 |
| Low | 0.3503 on 02/02/24 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 1.1000 on 05/24/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 94,919 | 298,239,616 | 188,144,976 | 165,876,912 | 120,503,200 |
| Shares Outstanding, K | 93,058 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 100,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -21,170,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 13,640,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -14,680,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.51 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 04/19/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/19/24 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.27 | 15.83 | 16.31 | 9.56 |